Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
61.43
-0.60 (-0.97%)
At close: Mar 5, 2026, 4:00 PM EST
60.43
-1.00 (-1.63%)
Pre-market: Mar 6, 2026, 7:48 AM EST
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $2.66 billion as of March 6, 2026. Its market cap has increased by 270.40% in one year.
Market Cap
2.66B
Enterprise Value
2.10B
1-Year Change
270.40%
Ranking
Category
Stock Price
$61.43
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $2.66B, an increase of 1,529.01%. That is a compound annual growth rate of 208.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 2.68B | 51.74% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Travere Therapeutics | 2.61B |
| Apellis Pharmaceuticals | 2.58B |
| Wave Life Sciences | 2.53B |
| Adaptive Biotechnologies | 2.48B |
| Disc Medicine | 2.46B |
| Immunome | 2.44B |
| Dyne Therapeutics | 2.41B |
| Ocular Therapeutix | 2.34B |